APA 6th Edition

Perić, P. (2013). Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia. Reumatizam, 60 (2), 181-182. Preuzeto s https://hrcak.srce.hr/123457

---

MLA 8th Edition

Perić, Porin. "Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia." Reumatizam, vol. 60, br. 2, 2013, str. 181-182. https://hrcak.srce.hr/123457. Citirano 05.01.2025.

---

Chicago 17th Edition

Perić, Porin. "Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia." Reumatizam 60, br. 2 (2013): 181-182. https://hrcak.srce.hr/123457

---

Harvard

Perić, P. (2013). 'Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia', Reumatizam, 60(2), str. 181-182. Preuzeto s: https://hrcak.srce.hr/123457 (Datum pristupa: 05.01.2025.)

---

Vancouver

Perić P. Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia. Reumatizam [Internet]. 2013 [pristupljeno 05.01.2025.];60(2):181-182. Dostupno na: https://hrcak.srce.hr/123457

---

IEEE

P. Perić, "Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia", Reumatizam, vol.60, br. 2, str. 181-182, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/123457. [Citirano: 05.01.2025.]